설명
Summary of therapeutic strategies targeting metal ion dysregulation in neurodegenerative diseases, including iron chelation, antioxidant supplementation, and metal transporter modulation.
More Figures from This Paper
Figure 3
Molecular pathways of iron metabolism and ferroptosis in the context of neurodegenerative disease. Excessive iron accumulation in neurons can trigger lipid peroxidation and cell death through ferroptotic mechanisms.
diagram
Figure 4
Schematic of copper homeostasis and cuproptosis mechanisms relevant to neurodegeneration. Copper imbalance has been implicated in the pathogenesis of Wilson's disease and may contribute to Alzheimer's disease progression.
diagram
Figure 5
Illustration of zinc and manganese transport and regulatory mechanisms in the central nervous system, highlighting how disruptions in metal ion balance may accelerate neurodegenerative processes.
diagram
Figure 7
Integrative model linking metal ion imbalance to multiple neurodegenerative disease mechanisms including oxidative stress, ferroptosis, cuproptosis, cellular senescence, and neuroinflammation.
diagramFigure 6
DiagramSource Paper
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.Cite This Figure
 > Source: Leilei Chen et al. "Homeostasis and metabolism of iron and other metal ions in neurodegenerative dis." *Signal transduction and targeted therapy*, 2025. PMID: [39894843](https://pubmed.ncbi.nlm.nih.gov/39894843/)
<figure> <img src="https://pdfs.citedhealth.com/figures/39894843/702.png" alt="Summary of therapeutic strategies targeting metal ion dysregulation in neurodegenerative diseases, including iron chelation, antioxidant supplementation, and metal transporter modulation." /> <figcaption>Figure 6. Summary of therapeutic strategies targeting metal ion dysregulation in neurodegenerative diseases, including iron chelation, antioxidant supplementation, and metal transporter modulation.<br> Source: Leilei Chen et al. "Homeostasis and metabolism of iron and other metal ions in neurodegenerative dis." <em>Signal transduction and targeted therapy</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39894843/">39894843</a></figcaption> </figure>